Refresh

Fresenius Kabi Oncology Ltd. - Research Center

532545 FKONCO Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 13 Mar ' 12 Mar ' 11 Mar ' 10 Mar ' 09
Income

Operating income

596.30 524.32 412.37 421.48 262.93
Expenses

Material consumed

187.30 237.48 148.34 126.44 77.96

Manufacturing expenses

22.21 31.29 25.30 33.41 32.48

Personnel expenses

70.32 60.98 56.11 47.59 71.70

Selling expenses

- - 18.69 18.30 17.67

Adminstrative expenses

173.47 128.63 63.55 83.19 131.34

Expenses capitalised

- - - - -

Cost of sales

453.30 458.38 311.98 308.93 331.16

Operating profit

143.00 65.94 100.39 112.55 -68.23

Other recurring income

1.80 2.90 5.66 6.13 12.30

Adjusted PBDIT

144.80 68.84 106.05 118.67 -55.93

Financial expenses

-2.60 17.66 18.03 19.40 21.97

Depreciation

25.79 23.97 16.92 12.51 11.81

Other write offs

- - - 0.46 0.46

Adjusted PBT

121.62 27.21 71.10 86.31 -90.17

Tax charges

34.22 20.75 20.76 5.87 2.78

Adjusted PAT

87.40 6.47 50.35 80.44 -92.95

Non recurring items

-6.81 44.48 -1.10 -0.21 15.26

Other non cash adjustments

- - - - -

Reported net profit

80.59 50.95 49.24 80.23 -77.70

Earnigs before appropriation

144.69 314.10 263.15 213.91 133.68

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

144.69 314.10 263.15 213.91 133.68
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com